DNA sources from liquid biopsies correlate to track MM progress

A paper published in Nature Communications showed concordance between sequencing of circulating free DNA (cfDNA) and circulating tumor cell (CTC) DNA, suggesting the methods could replace bone marrow biopsies to genetically monitor multiple myeloma patients.

Bone

Read the full 353 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE